Login to Your Account

Financings Roundup

Wednesday, May 22, 2013
• Epizyme Inc., of Cambridge, Mass., set terms for its proposed initial public offering (IPO), aiming to sell 4.3 million shares at a price range of $13 to $15.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription